Ying and his colleagues proved that ANK2 was overexpressed in pancreatic ductal adenocarcinoma and inhibition of ANK2 reduced invasion ability of pancreatic cancer cells [27]. This evidence concerns the gene ANK2 and pancreatic ductal adenocarcinoma.